Biopharma’s golden parachutes: 12 execs who took in the biggest M&A windfalls of $35M+
Twelve biopharma execs collected nearly $1B in golden parachutes from 2025–26 M&A deals, led by Cidara's Jeffrey Stein ($221M) and Arcellx's Rami Elghandour ($137M).